• Exchange: AktieTorget
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Generic Pharma

PharmaLundensis AB

+ Add to Watchlist

PHAL:SS

7.4500 SEK 0.0500 0.67%

As of 12:00:00 ET on 11/20/2014.

Snapshot for PharmaLundensis AB (PHAL)

Open: 7.2000 Day's Range: 6.6000 - 7.4500 Volume: 2,525
Previous Close: 7.5000 52wk Range: 5.5000 - 11.9000 1-Yr Rtn: -14.37%

Stock Chart for PHAL

No chart data available.
  • PHAL:SS 7.4500
  • 1D
  • 1M
  • 1Y
7.5000
Interactive PHAL Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for PHAL

Current P/E Ratio (ttm) -
Estimated P/E(-) -
Relative P/E vs. OMX -
Earnings Per Share (ttm) -0.3900
Est. EPS -
Est. PEG Ratio -
Market Cap (M SEK) 126.83
Shares Outstanding (M) 17.02
30 Day Average Volume 3,911
Price/Book (mrq) 10.7144
Price/Sale (ttm) 15,508.2313
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 02/20/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for PHAL

  • Revenue
  • Net Income (M/SEK)
  • Profit Margin (%)

Company Profile & Key Executives for PHAL

PharmaLundensis AB is a drug development company. The Company is developing a drug for the treatment of Chronic obstructive pulmonary disease.

Staffan SkogvallCEO/Director:Research
More Company Profile & Key Executives for PHAL

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil